Orlistat Augments Postprandial Increases In Glucagon-Like Peptide-1 in Obese Type 2 Diabetic Patients
Response to Horowitz et al.
- Taner Damci, MD1,
- Serap Yalin, MD1,
- Huriye Balci, PHD2,
- Zeynep Osar, MD1,
- Ustun Korugan, MD1,
- Mucahit Ozyazar, MD1 and
- Hasan Ilkova, MD2
- 1Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Istanbul University Cerrahpasa Medical School, Istanbul, Turkey
- 2Central Laboratories, Istanbul University Cerrahpasa Medical School, Istanbul, Turkey
- Address correspondence to Taner Damci, MD, Atakoy 4, Kisim O-67 D:7, 34750 Atakoy, Istanbul, Turkey. E-mail: tdamci{at}superonline.com
We thank Horowitz et al. (1) for their comments on our article (2) on the effect of orlistat on postprandial glucose, insulin, and incretin levels. They raise criticisms regarding the increase in postprandial GLP-1 levels, asserting that it is …
